Skip to main content
Jakub Tolar, MD, Pediatric Hematology & Oncology, Minneapolis, MN

JakubTolarMDPhD

Pediatric Hematology & Oncology Minneapolis, MN

Pediatric Hematologic Oncology

Dean of the University of Minnesota Medical School, Vice President for Clinical Affairs, University of Minnesota- Twin Cities Co-Lead M Health Fairview Joint Clinical Enterprise Campus Public Health Officer, University of Minnesota Board Chair, University of Minnesota Physicians

Dr. Tolar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tolar's full profile

Already have an account?

  • Office

    420 Delaware Street SE
    Minneapolis, MN 55455

Summary

  • I am a physician-scientist (pediatric hematology-oncology and bone marrow transplant surgeon) focused on finding new ways of treating children with lethal genetic diseases- like EB, Hurler syndrome and others.

    In addition to my research and clinical care, I serve as Dean of the University of Minnesota Medical School and Vice President for Clinical Affairs at the University of Minnesota. I also serve as the Campus Public Health Officer for the U of M School system. I also serve as Board Chair for the University of Minnesota Physicians (M Physicians), a multi-specialty group practice for the University of Minnesota Medical School faculty. Lastly, I am the co-lead for our joint clinical enterprise, M Health Fairview.
  • Dr. Jakub Tolar DEAN OF THE UNIVERSITY OF MINNESOTA MEDICAL SCHOOL

    The University of Minnesota Medical School educates physicians. That's an important part of academic medicine. But that's not all we do.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1997 - 2000
  • University of Minnesota
    University of MinnesotaPh.D., Molecular, Cellular & Developmental Biology and Genetics, 1992 - 1996
  • Charles University in Prague Faculty of Medicine
    Charles University in Prague Faculty of MedicineClass of 1990, Summa Cum Laude
  • Na Vitezne Plani
    Na Vitezne PlaniB.S., Examination of Maturity, Summa Cum Laude, 1980 - 1984

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1999 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Best Doctors in America BestDoctors.com, 2012, 2017-2018
  • Top Doctors Minneapolis St. Paul Magazine, 2010, 2012-2018
  • Elected to Academic Health Center's Academy for Excellence in Health Research University of Minnesota, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho  
    Bruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology
  • Outcome of Haematopoietic Stem Cell Transplantation in Dyskeratosis Congenita*  
    Jakub Tolar, MD, British Journal of Haematology
  • Prediction of DNA-binding propensity of proteins by the ball-histogram method  
    Szaboova A, KuZelka O, Morales E, Zelezny F, Tolar J, Lect Notes Comput Sc, 1/1/2011
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Plasma and intracellular population pharmacokinetic analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients.
    Long-Boyle J, Sambol N, Dvorak CC, Cowan MJ, Lee S, Huang LS, Horn B, Stricherz M, Tolar J, Orchard P, Jacobson P, Aweeka F, Biol Blood Marrow Transplant, 1/1/2014
  • Toxic epidermal necrolysis (TEN) in recessive dystrophic epidermolysis bullosa status post hematopoietic stem cell transplant.
    Sajic D, Hook K, Tolar J, 89th Canadian Dermatology Association Annual Conference, 1/1/2014
  • Effects of vitronectin on neural differentiation and proliferation of human iPSC’s in 3D cell culture.
    Venhuizen S, Lindborg B, Haider K, Ulrich C, Vegoe A, Subramaniam S, Brekke JH, Dutton J, Tolar J, O’Brien TD, Cornell University Merial-NIH Veterinary Scholars Symposium, 1/1/2014
  • Join now to see all

Lectures

  • Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophi... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Cellular Therapy: Concepts and Plans 
    Osaka, Japan - 1/14/2014
  • Immunity in Genetic Disorders, Cancer, and Bone Marrow Transplant 
    University of Minnesota Children’s Hospital, Minneapolis, MN - 1/11/2014
  • Join now to see all

Other

  • Biological characterization of naturally occurring mutations in an oncogenic variant of human papillomavirus type 11, PhD thesis, directed by Anthony J. Faras, PhD. 
    Tolar J
    1/1/1996

Press Mentions

  • When You Think of University of Minnesota Medicine, Do You Think of Community Health?
    When You Think of University of Minnesota Medicine, Do You Think of Community Health?June 21st, 2024
  • Celebrating the Medical School’s Distinguished Graduates
    Celebrating the Medical School’s Distinguished GraduatesMay 6th, 2024
  • Supporting the U of M Enhances Rural Health Care Access
    Supporting the U of M Enhances Rural Health Care AccessApril 19th, 2023
  • Join now to see all

Professional Memberships

Other Languages

  • Czech